HIGHLIGHTS
- who: Hyejeong Kim from the Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, have published the research work: Long-term administration of CU06-1004 ameliorates cerebrovascular aging and BBB injury in aging mouse model, in the Journal: (JOURNAL)
- what: The authors investigated the protective effects of CU06-1004 against oxidative stress-induced damage in human brain microvascular endothelial cells (HBMECs). The authors report the novel finding that long-term oral CU06-1004 administration improves age-associated cerebral microvascular rarefaction in aged mice. The trial was repeated three times for each mouse, and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.